Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Ariad Pharma Discontinues Phase III Trial of Ponatinib (Iclusig) in Leukemia Patients

 

Ariad Pharma Discontinues Phase III Trial of Ponatinib (Iclusig) in Leukemia Patients

2013-10-20 13:07:47| Biotech - Topix.net

Ariad Pharmaceuticals, Inc. has announced that it is discontinuing the phase III EPIC trial of ponatinib in patients with newly diagnosed chronic myeloid leukemia .

Tags: iii trial phase patients

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

04.11 Tropical Depression Eighteen Graphics 04.11 Tropical Depression Eighteen Public Advisory Number 4A 04.11 Remnants of Patty Graphics 04.11 Atlantic Tropical Weather Outlook 04.11 Eastern North Pacific Tropical Weather Outlook 04.11 Paper Excellence Group Rebrands as Domtar 04.11 Registration Open for 2025 Waterborne Symposium 04.11 ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending More »